lactic acid has been researched along with Diabetic Cardiomyopathies in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In contrast, type 2 diabetes makes the heart metabolise more fatty acids." | 1.43 | Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation. ( Aasum, E; Aksentijevic, D; Carr, CA; Clarke, K; Cole, MA; Heather, LC; Le Page, L; Lund, T; Mansor, LS; Mehta, K; Shattock, MJ; Sousa Fialho, Mda L; Tyler, DJ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, SY | 1 |
| Zhu, S | 1 |
| Wu, J | 1 |
| Zhang, M | 1 |
| Xu, Y | 1 |
| Xu, W | 1 |
| Cui, J | 1 |
| Yu, B | 1 |
| Cao, W | 1 |
| Liu, J | 1 |
| Mansor, LS | 1 |
| Mehta, K | 1 |
| Aksentijevic, D | 1 |
| Carr, CA | 1 |
| Lund, T | 1 |
| Cole, MA | 1 |
| Le Page, L | 1 |
| Sousa Fialho, Mda L | 1 |
| Shattock, MJ | 1 |
| Aasum, E | 1 |
| Clarke, K | 1 |
| Tyler, DJ | 1 |
| Heather, LC | 1 |
2 other studies available for lactic acid and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Blood Pressure; Cells, Cultured; Dia | 2020 |
Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation.
Topics: Adaptation, Physiological; Animals; Cell Hypoxia; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathi | 2016 |